SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " SK Life Science, Inc " 4 found 🔀 AI-powered Shuffle
Sign in to save shuffle history.
SK Life Science, Inc. Announces FDA Acceptance for Review of New Drug Application for Cenobamate Oral Suspension
Key Facts: FDA has accepted for review the New Drug Application (NDA) for an investigational oral suspension formulation of cenobamate for the treatment of...
SK Life Science Supports SUDEP Awareness Efforts Through Partnership with CURE Epilepsy and The Cameron Boyce Foundation
/PRNewswire/ -- SK Life Science, Inc., a U.S. pharmaceutical company and part of SK Biopharmaceuticals, today announced its support of SUDEP awareness...
SK Life Science, Inc. Launches Epilepsy Connect to Empower Advanced Practice Providers in Epilepsy Care
Key Facts: SK Life Science, Inc. has launched Epilepsy Connect, a new digital platform designed to empower advanced practice providers (APPs) in epilepsy care....
SK Life Science, Inc. to Present New Data and Epilepsy Insights at the 2026 American Academy of Neurology Annual Meeting
Key Facts: SK Life Science, Inc. will present multiple posters at the American Academy of Neurology (AAN) Annual Meeting (April 18–22, 2026, Chicago, Illinois)...